Gamida Cell Presents Omidubicel Phase 3 Data in Patients with High-Risk Hematologic Malignancies
Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]
Gamida Cell presented results of a Phase 3 clinical study of omidubicel in an oral session at the Transplantation & […]
AstraZeneca reported positive results from the phase 3 ELEVATE-RR trial, which evaluated AstraZeneca’s Calquence (acalabrutinib) versus ibrutinib in adults with previously treated, […]
Agios Pharmaceuticals announced results from the phase 3 ACTIVATE-T trial of mitapivat in regularly transfused adults with Pyruvate Kinase (PK) deficiency. […]
BioMarin announced positive topline results from its ongoing global Phase 3 GENEr8-1 study of valoctocogene roxaparvovec, an investigational gene therapy […]
Constellation Pharmaceuticals announced positive preliminary data from its Phase II MANIFEST and Phase III MANIFEST-2 clinical trials evaluating CPI-0610 for […]
A Baylor College of Medicine and Texas Children’s Cancer Center research team has been awarded a $1.4 million gift over […]
Uniqure announced positive top-line data from its pivotal, Phase III HOPE-B gene therapy trial of etranacogene dezaparvovec, an adeno-associated virus five […]
GenMab announced positive topline results from the second part of the Phase 3 CASSIOPEIA (MMY3006) study of daratumumab monotherapy as […]
UT Southwestern research shows the effectiveness of a treatment for aplastic anemia while revealing a range of diagnosis and treatment […]
Astex Pharmaceuticals and Otsuka Pharmaceuticals announced top-line results of the ASTRAL-2 and ASTRAL-3 clinical studies that evaluated the efficacy and […]